The NHS is rolling out a new injectable form of pembrolizumab (Keytruda) which can slash the time the treatment takes by up to 90%, to help patients spend less time in hospital while improving NHS productivity.

The jab can be used to treat 14 different cancer types, including lung, breast, head and neck, and cervical, and works by triggering immune cells to recognise and kill cancer cells.

Read more – NHSE (4/5/26)